4045-27-6

Usage

Uses

Used in Pharmaceutical Industry:
1-acetyl-3-piperidinol (SALTDATA: FREE) is used as a building block for the synthesis of various pharmaceuticals and drugs. Its versatile nature and reactivity make it a key component in the development of new medications.
Used in Medication Production:
1-acetyl-3-piperidinol (SALTDATA: FREE) is used as an intermediate in the production of medications like fentanyl, an opioid analgesic, and pethidine, a synthetic opioid painkiller. Its role in the synthesis process is crucial for creating effective pain management solutions.
Used in Chemical Field:
1-acetyl-3-piperidinol (SALTDATA: FREE) has a wide range of applications in the chemical field due to its reactivity and ability to form various compounds. It serves as a valuable intermediate for the development of new chemical products and processes.

Upstream product

• 6859-99-0 3-hydroxypiperazine 
• 108-24-7 acetic anhydride 
• 109-00-2 3-HYDROXYPYRIDINE 
• 75-36-5 acetyl chloride 

Downstream Products

• 676360-83-1 1-{3-[4-(3-Chloro-4-methoxy-phenylamino)-6-cycloheptylamino-[1,3,5]triazin-2-yloxy]-piperidin-1-yl}-ethanone 

Relevant academic research and scientific papers

SUBSTITUTED 5-CYANOINDOLE COMPOUNDS AND USES THEREOF

A compound of Formula (I), or a pharmaceutically acceptable salt thereof, is provided that has been shown to be useful for the treatment of lysine (K)-specific demethylase 1A (LSD1) - mediated diseases or disorders, Formula (I), wherein R1, R2, R3, R4, and R5 are as defined herein.

BRUTON'S TYROSINE KINASE INHIBITORS

Disclosed herein are compounds that form covalent bonds with Bruton's tyrosine kinase (BTK). Methods for the preparation of the compounds are disclosed. Also disclosed are pharmaceutical compositions that include the compounds. Methods of using the BTK inhibitors are disclosed, alone or in combination with other therapeutic agents, for the treatment of autoimmune diseases or conditions, heteroimmune diseases or conditions, cancer, including lymphoma, and inflammatory diseases or conditions. (Formula I)

Piperazine- and piperidine-derivatives as melanocortin receptor agonists

The present invention relates to melanocortin receptor agonists of formula I, which is useful in the treatment of obesity, diabetes and male and/or female sexual dysfunction.

Sulfamylbenzoic acids

Certain mono- and disubstituted-5-sulfamylbenzoic acids, many of which are novel, and their use in lowering blood lipid levels in mammals.